Bacil Pharma Share Price
15.30+0.72 (+4.94%)
-56.36% past 1 Year
Bacil Pharma Limited, incorporated in the year 1987, is a public limited company. The main object of the Company is to undertake Pharmaceutical business. The company manufactures bulk pharmaceutical/ chemical,
Corporate filings & documents
Announcements
Annual Report for the Financial Year 2025-2026
3 days agoAnnual Report for the Financial Year 2025-2026
3 days agoNotice of Annual General Meeting to be held on 23rd September 2026
5 days agoIntimation for Book Closure for the purpose of Annual General Meeting
5 days agoIntimation for Book Closure for the purpose of Annual General Meeting
5 days agoOutcome of Board Meeting held on 29th August 2026
5 days agoOutcome of Board Meeting held on 29th August 2026
5 days agoBacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2026 inter alia to consider and approve Discussion on Notice for 39th Annual General Meeting for the Company. Discussion on Approval of Director Report of the Company for the Financial Year 2025-2026. Discussion to Fix Date Place and Timing of 39th Annual General Meeting of the Company Any other business with the permission of Chairperson.
1 week agoBacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2026 inter alia to consider and approve Discussion on Notice for 39th Annual General Meeting for the Company. Discussion on Approval of Director Report of the Company for the Financial Year 2025-2026. Discussion to Fix Date Place and Timing of 39th Annual General Meeting of the Company Any other business with the permission of Chairperson.
1 week agoAppointment of Director
1 week agoAppointment of Director
1 week agoOutcome of Board Meeting held on 25th August 2026
1 week agoOutcome of Board Meeting held on 25th August 2026
1 week agoBacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 inter alia to consider and approve Board meeting to be held on 25th August 2026 for Discussion on Appointment of Directors
2 weeks agoUn-audited Financial Results for the Quarter Ended 30th June 2026
3 weeks agoUn-audited Financial Results for the Quarter Ended 30th June 2026
3 weeks agoOutcome of Board Meeting held on 12th August 2026
3 weeks agoOutcome of Board Meeting held on 12th August 2026
3 weeks agoBacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Intimation of Board Meeting for approval of unaudited financial results for the quarter ended 30th June 2026
4 weeks agoBacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Intimation of Board Meeting for approval of unaudited financial results for the quarter ended 30th June 2026
4 weeks agoRegarding the incorporation of a wholly owned subsidiary of the company named Bacil Research & Development Private Limited.
1 month agoRegarding the incorporation of a wholly owned subsidiary of the company named Bacil Research & Development Private Limited.
1 month agoAttached Resignation of Directors as Query raised from BSE
1 month agoAttached Resignation of Directors as Query raised from BSE
1 month agoCompliance Certificate 74 (5) for the Quarter Ended 30th June 2026
1 month agoCompliance Certificate 74 (5) for the Quarter Ended 30th June 2026
1 month agoAttached Resignation of Directors as query raised from BSE
1 month agoAttached Resignation of Directors as query raised from BSE
1 month agoAs Per Announcement
1 month agoAs Per Announcement
1 month agoAs Per Announcement
1 month agoAs Per Announcement
1 month agoAs Per Announcement
1 month agoAs Per Announcement
1 month agoIntimation regarding Approval of Name for Proposed Wholly-owned Subsidiary
1 month agoIntimation regarding Approval of Name for Proposed Wholly-owned Subsidiary
1 month agoBacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 inter alia to consider and approve 1. The proposal for raising funds by way of a Rights Issue of equity shares to the eligible equity shareholders of the Company for an aggregate amount of up to ?50 00 00 000 (Rupees Fifty Crores Only) in accordance with the applicable provisions of the Companies Act 2013 the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 the SEBI (LODR) Regulations 2015 and other applicable laws.2. The proposal for increase in the Authorised Share Capital of the Company.3. Consequent alteration of the Capital Clause of the Memorandum of Association of the Company. 4. To determine and approve the detailed terms and conditions of the Rights Issue including but not limited to the issue size rights entitlement ratio issue price record date rights issue schedule appointment of intermediaries draft Letter of Offer and such other matters incidental or connected therewith.5. Discussion on Appointment and Resignation of Directors.
2 months agoBacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 inter alia to consider and approve 1. The proposal for raising funds by way of a Rights Issue of equity shares to the eligible equity shareholders of the Company for an aggregate amount of up to ?50 00 00 000 (Rupees Fifty Crores Only) in accordance with the applicable provisions of the Companies Act 2013 the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 the SEBI (LODR) Regulations 2015 and other applicable laws.2. The proposal for increase in the Authorised Share Capital of the Company.3. Consequent alteration of the Capital Clause of the Memorandum of Association of the Company. 4. To determine and approve the detailed terms and conditions of the Rights Issue including but not limited to the issue size rights entitlement ratio issue price record date rights issue schedule appointment of intermediaries draft Letter of Offer and such other matters incidental or connected therewith.5. Discussion on Appointment and Resignation of Directors.
2 months agoIntimation for Appointment of Independent Director
2 months agoIntimation for Appointment of Independent Director
2 months agoWithdrawal of Intimation for Appointment of Independent Directors
2 months agoIntimation of Appointment of Additional Non-Executive Independent Director
2 months agoIntimation of Appointment of Additional Non-Executive Independent Director
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Niraj Rajnikant Shah
2 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Niraj Rajnikant Shah
2 months agoAs per Attached outcome of meeting
2 months agoAs per Attached outcome of meeting
2 months agoIntimation of Closure of Trading Window
2 months agoIntimation of Closure of Trading Window
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Manubhai Shah
2 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
G2 & G3 Samarpan Complex Next To Mirador Hotel Chakala, Andheri (East) Mumbai Maharashtra PIN: 400099 Tel No: 022 22618452 / 22661541 Fax No: 022 22618327 Email: [email protected] / [email protected] Internet: www.bacilpharma.co.in
Registrars
E-2, Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Mumbai Maharashtra E-2/3, Ansa Industrial Estate Saki Vihar Road Saki Naka PIN: Tel No: 91-022–62638200 Fax No: NULL Email: NULL Internet: www.bigshareonline.com
Management
Dinesh Chander Notiyal, Non Executive Independent Director
Avani Savjibhai Godhaniya, Non Executive Independent Director
Chaitali Kalpataru Shah, Executive Director & Chief Financial Officer
Vivek Mukesh Yadav, Non Executive Independent Director
Dikshant Singh Panwar, Company Secretary
Details
BSE 524516
NSE NULL
ISIN INE711D01018